|
|
|
|
LEADER |
01716nam a22003015i 4500 |
001 |
000280935 |
005 |
20210720140613.0 |
007 |
cr nn 008mamaa |
008 |
161123s2016 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781493964604
|
024 |
7 |
|
|a 10.1007/978-1-4939-6460-4
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Frontiers in Cancer Research :
|b Evolutionary Foundations, Revolutionary Directions /
|c edited by Carlo C. Maley, Mel Greaves.
|
250 |
|
|
|a 1st ed. 2016.
|
260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2016.
|
300 |
|
|
|a XIV, 258 p. 28 illus., 17 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a 1. The Evolutionary Foundations of Cancer Research -- 2. The Role of Theory in Cancer Research -- 3. Population Genetics of Neoplasms -- 4. Diversity in Neoplasms -- 5. How do Mutant Clones Expand in Normal Tissue? -- 6. Cancer Stem Cells in Tumor Evolution -- 7. Measuring Rather than Imagining Somatic Cell Selection and Clonal Evolution -- 8. The Darwinian Dynamics of Motility and Metastasis -- 9. Applying Evolutionary Principles to Cancer Therapy -- 10. Mismatches with Our Ancestral Environments and Cancer Risk -- 11. The Evolution of Cancer Suppression Mechanisms -- 12. Epilogue: How can we Thwart the Evolutionary Resilience of Cancer?.
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
1 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
700 |
1 |
|
|a Maley, Carlo C.
|e editor.
|
700 |
1 |
|
|a Greaves, Mel.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|